247 related articles for article (PubMed ID: 29579079)
21. A comprehensive gene expression analysis at sequential stages of in vitro cardiac differentiation from isolated MESP1-expressing-mesoderm progenitors.
den Hartogh SC; Wolstencroft K; Mummery CL; Passier R
Sci Rep; 2016 Jan; 6():19386. PubMed ID: 26783251
[TBL] [Abstract][Full Text] [Related]
22. MESP1 knock-down in human iPSC attenuates early vascular progenitor cell differentiation after completed primitive streak specification.
Eskildsen TV; Ayoubi S; Thomassen M; Burton M; Mandegar MA; Conklin BR; Jensen CH; Andersen DC; Sheikh SP
Dev Biol; 2019 Jan; 445(1):1-7. PubMed ID: 30389344
[TBL] [Abstract][Full Text] [Related]
23. Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells.
Zanella F; Sheikh F
Methods Mol Biol; 2016; 1353():147-62. PubMed ID: 25520292
[TBL] [Abstract][Full Text] [Related]
24. Dual reporter MESP1 mCherry/w-NKX2-5 eGFP/w hESCs enable studying early human cardiac differentiation.
Den Hartogh SC; Schreurs C; Monshouwer-Kloots JJ; Davis RP; Elliott DA; Mummery CL; Passier R
Stem Cells; 2015 Jan; 33(1):56-67. PubMed ID: 25187301
[TBL] [Abstract][Full Text] [Related]
25. From fibroblast cells to cardiomyocytes: direct lineage reprogramming.
Yang L
Stem Cell Res Ther; 2011 Jan; 2(1):1. PubMed ID: 21241459
[TBL] [Abstract][Full Text] [Related]
26. Pitx2c modulates cardiac-specific transcription factors networks in differentiating cardiomyocytes from murine embryonic stem cells.
Lozano-Velasco E; Chinchilla A; Martínez-Fernández S; Hernández-Torres F; Navarro F; Lyons GE; Franco D; Aránega AE
Cells Tissues Organs; 2011; 194(5):349-62. PubMed ID: 21389672
[TBL] [Abstract][Full Text] [Related]
27. Intermediate Reprogramming of Mouse Skin Fibroblasts into Stem-Like Cells by Bone Morphogenetic Protein 4.
Lee SE; Uhm SJ; Son YJ; Park YG; Kim EY; Park SP
Cell Reprogram; 2017 Apr; 19(2):107-115. PubMed ID: 28170287
[TBL] [Abstract][Full Text] [Related]
28. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
29. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
Bilic J; Izpisua Belmonte JC
Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
[TBL] [Abstract][Full Text] [Related]
30. Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Burridge PW; Diecke S; Matsa E; Sharma A; Wu H; Wu JC
Methods Mol Biol; 2016; 1353():119-30. PubMed ID: 25690476
[TBL] [Abstract][Full Text] [Related]
31. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
32. High glucose suppresses embryonic stem cell differentiation into cardiomyocytes : High glucose inhibits ES cell cardiogenesis.
Yang P; Chen X; Kaushal S; Reece EA; Yang P
Stem Cell Res Ther; 2016 Dec; 7(1):187. PubMed ID: 27938398
[TBL] [Abstract][Full Text] [Related]
33. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
34. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.
Protze S; Khattak S; Poulet C; Lindemann D; Tanaka EM; Ravens U
J Mol Cell Cardiol; 2012 Sep; 53(3):323-32. PubMed ID: 22575762
[TBL] [Abstract][Full Text] [Related]
35. Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells.
Geuss LR; Suggs LJ
Biotechnol Prog; 2013; 29(5):1089-96. PubMed ID: 23956196
[TBL] [Abstract][Full Text] [Related]
36. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
[TBL] [Abstract][Full Text] [Related]
37. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival.
Jara-Avaca M; Kempf H; Rückert M; Robles-Diaz D; Franke A; de la Roche J; Fischer M; Malan D; Sasse P; Solodenko W; Dräger G; Kirschning A; Martin U; Zweigerdt R
Stem Cell Reports; 2017 Feb; 8(2):305-317. PubMed ID: 28089668
[TBL] [Abstract][Full Text] [Related]
38. Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes.
Tan X; Dai Q; Guo T; Xu J; Dai Q
Biochem Biophys Res Commun; 2018 Jan; 495(4):2490-2497. PubMed ID: 29217199
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling.
Chen Y; Zeng D; Ding L; Li XL; Liu XT; Li WJ; Wei T; Yan S; Xie JH; Wei L; Zheng QS
BMC Cell Biol; 2015 Sep; 16():22. PubMed ID: 26335746
[TBL] [Abstract][Full Text] [Related]
40. Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes.
Chu AJ; Zhao EJ; Chiao M; Lim CJ
PLoS One; 2020; 15(4):e0230966. PubMed ID: 32243463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
